OF, H., E, U., G, O., H, W., K, I., T, O., . . . S, H. (2021). Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 139, 111633. https://doi.org/10.1016/j.biopha.2021.111633
Chicago Style (17th ed.) CitationOF, Hatipoglu, et al. "Osteopontin Silencing Attenuates Bleomycin-induced Murine Pulmonary Fibrosis by Regulating Epithelial-mesenchymal Transition." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 139 (2021): 111633. https://doi.org/10.1016/j.biopha.2021.111633.
MLA (9th ed.) CitationOF, Hatipoglu, et al. "Osteopontin Silencing Attenuates Bleomycin-induced Murine Pulmonary Fibrosis by Regulating Epithelial-mesenchymal Transition." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 139, 2021, p. 111633, https://doi.org/10.1016/j.biopha.2021.111633.